Alcohol consumption's attributable disease burden and cost-effectiveness of targeted public health interventions: a systematic review of mathematical models.


Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
26 Oct 2019
Historique:
received: 07 12 2018
accepted: 11 10 2019
entrez: 28 10 2019
pubmed: 28 10 2019
medline: 20 12 2019
Statut: epublish

Résumé

Around 6% of total deaths are related to alcohol consumption worldwide. Mathematical models are important tools to estimate disease burden and to assess the cost-effectiveness of interventions to address this burden. We carried out a systematic review on models, searching main health literature databases up to July 2017. Pairs of reviewers independently selected, extracted data and assessed the quality of the included studies. Discrepancies were resolved by consensus. We selected those models exploring: a) disease burden (main metrics being attributable deaths, disability-adjusted life years, quality-adjusted life years) or b) economic evaluations of health interventions or policies, based on models including the aforementioned outcomes. We grouped models into broad families according to their common central methodological approach. Out of 4295 reports identified, 63 met our inclusion criteria and were categorized in three main model families that were described in detail: 1) State transition -i.e Markov- models, 2) Life Table-based models and 3) Attributable fraction-based models. Most studies pertained to the latter one (n = 29, 48.3%). A few miscellaneous models could not be framed into these families. Our findings can be useful for future researchers and decision makers planning to undertake alcohol-related disease burden or cost-effectiveness studies. We found several different families of models. Countries interested in adopting relevant public health measures may choose or adapt the one deemed most convenient, based on the availability of existing data at the local level, burden of work, and public health and economic outcomes of interest.

Sections du résumé

BACKGROUND BACKGROUND
Around 6% of total deaths are related to alcohol consumption worldwide. Mathematical models are important tools to estimate disease burden and to assess the cost-effectiveness of interventions to address this burden.
METHODS METHODS
We carried out a systematic review on models, searching main health literature databases up to July 2017. Pairs of reviewers independently selected, extracted data and assessed the quality of the included studies. Discrepancies were resolved by consensus. We selected those models exploring: a) disease burden (main metrics being attributable deaths, disability-adjusted life years, quality-adjusted life years) or b) economic evaluations of health interventions or policies, based on models including the aforementioned outcomes. We grouped models into broad families according to their common central methodological approach.
RESULTS RESULTS
Out of 4295 reports identified, 63 met our inclusion criteria and were categorized in three main model families that were described in detail: 1) State transition -i.e Markov- models, 2) Life Table-based models and 3) Attributable fraction-based models. Most studies pertained to the latter one (n = 29, 48.3%). A few miscellaneous models could not be framed into these families.
CONCLUSIONS CONCLUSIONS
Our findings can be useful for future researchers and decision makers planning to undertake alcohol-related disease burden or cost-effectiveness studies. We found several different families of models. Countries interested in adopting relevant public health measures may choose or adapt the one deemed most convenient, based on the availability of existing data at the local level, burden of work, and public health and economic outcomes of interest.

Identifiants

pubmed: 31655600
doi: 10.1186/s12889-019-7771-4
pii: 10.1186/s12889-019-7771-4
pmc: PMC6815367
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1378

Subventions

Organisme : Ministerio de Salud, Argentina
ID : Becas Salud Investiga 2017

Références

Drug Alcohol Rev. 2006 Nov;25(6):553-65
pubmed: 17132573
BMC Public Health. 2012 Jan 31;12:91
pubmed: 22293064
BMC Public Health. 2015 May 10;15:482
pubmed: 25958382
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
PLoS One. 2017 Mar 10;12(3):e0173704
pubmed: 28282416
Appl Health Econ Health Policy. 2012 May 1;10(3):145-62
pubmed: 22439628
Eur Addict Res. 2009;15(1):56-62
pubmed: 19052463
Health Policy. 2007 Nov;84(1):75-88
pubmed: 17403551
Aust N Z J Public Health. 2010 Jul;34 Suppl 1:S47-51
pubmed: 20618294
Addiction. 2017 Jun;112(6):946-967
pubmed: 28060453
Lancet. 2010 Apr 17;375(9723):1355-64
pubmed: 20338629
Eur J Public Health. 2002 Sep;12(3):214-23
pubmed: 12232962
S Afr Med J. 2007 Aug;97(8 Pt 2):664-72
pubmed: 17952223
IMA J Math Appl Med Biol. 2001 Jun;18(2):119-30
pubmed: 11453465
Lancet. 2009 Jun 27;373(9682):2223-33
pubmed: 19560604
Swiss Med Wkly. 2014 May 20;144:w13947
pubmed: 24845076
Addiction. 2006 Aug;101(8):1086-95
pubmed: 16869838
PLoS One. 2013;8(1):e51923
pubmed: 23300957
Eur Addict Res. 2011;17(2):72-9
pubmed: 21150206
Trop Med Int Health. 2016 Jan;21(1):52-60
pubmed: 26448195
BMJ. 2014 Sep 30;349:g5452
pubmed: 25270743
Aust N Z J Public Health. 2002 Oct;26(5):443-50
pubmed: 12413289
Health Econ. 2015 Oct;24(10):1368-1388
pubmed: 25270223
Eur J Public Health. 2017 Apr 1;27(2):345-351
pubmed: 27558943
BMC Fam Pract. 2014 Feb 06;15:26
pubmed: 24502342
Med J Aust. 2010 Apr 19;192(8):439-43
pubmed: 20402606
PLoS One. 2009 May 27;4(5):e5696
pubmed: 19479081
Int J Methods Psychiatr Res. 2008;17(3):141-51
pubmed: 18763694
Alcohol Alcohol. 2013 Mar-Apr;48(2):180-8
pubmed: 23015608
Eur J Health Econ. 2008 Nov;9(4):351-60
pubmed: 18043953
Appl Health Econ Health Policy. 2015 Aug;13(4):325-40
pubmed: 26129810
PLoS One. 2012;7(5):e33317
pubmed: 22590491
Alcohol Res. 2013;35(2):174-83
pubmed: 24881325
Value Health. 2009 Mar-Apr;12(2):253-61
pubmed: 20667060
Addiction. 2009 Oct;104(10):1646-55
pubmed: 21265906
BMC Med. 2008 Nov 28;6:36
pubmed: 19040717
J Glob Health. 2017 Jun;7(1):010404
pubmed: 28400952
Math Popul Stud. 1998;7(1):29-49, 109
pubmed: 12321476
BMC Health Serv Res. 2016 Apr 13;16:127
pubmed: 27074871
Med J Aust. 2013 Nov 4;199(9):619-22
pubmed: 24182229
N Z Med J. 2015 Feb 20;128(1409):15-28
pubmed: 25721958
PLoS One. 2014 Aug 25;9(8):e99906
pubmed: 25153324
Rev Panam Salud Publica. 2005 Oct-Nov;18(4-5):241-8
pubmed: 16354420
Eur Addict Res. 2003 Oct;9(4):157-64
pubmed: 12970584
Lancet. 2018 Sep 22;392(10152):1015-1035
pubmed: 30146330
Drug Alcohol Rev. 2012 Jan;31(1):4-12
pubmed: 21355934
JAMA. 2000 Apr 19;283(15):2008-12
pubmed: 10789670
Health Econ. 2006 Dec;15(12):1295-310
pubmed: 16941543
Addiction. 2016 Oct;111(10):1806-13
pubmed: 27085097
Am J Prev Med. 2008 Feb;34(2):143-152
pubmed: 18201645
BMJ Open. 2017 May 17;7(5):e015441
pubmed: 28515197
Value Health. 2012 Sep-Oct;15(6):812-20
pubmed: 22999130
Curr Epidemiol Rep. 2016 Sep;3(3):201-211
pubmed: 27547696
Alcohol Clin Exp Res. 2010 Aug;34(8):1442-9
pubmed: 20528821
J Stud Alcohol. 2004 Nov;65(6):782-93
pubmed: 15700517
Subst Abuse Treat Prev Policy. 2009 Nov 25;4:20
pubmed: 19939238
Ann Oper Res. 2016;236:149-176
pubmed: 26770007
Rev Panam Salud Publica. 2015 Dec;38(6):442-9
pubmed: 27440091
N Z Med J. 2005 Apr 15;118(1213):U1412
pubmed: 15843841
PLoS One. 2014 Feb 05;9(2):e88041
pubmed: 24505370
Prev Med. 2012 Sep;55(3):237-43
pubmed: 22713346
Int J Public Health. 2012 Apr;57(2):391-401
pubmed: 21465246

Auteurs

Ariel Esteban Bardach (AE)

Centre for Research in Epidemiology and Public Health, Institute for Clinical Effectiveness and Health Policy (IECS-CONICET), Dr Emilio Ravignani 2024 (C1014CPV), Buenos Aires, Argentina. abardach@iecs.org.ar.

Andrea Olga Alcaraz (AO)

Institute for Clinical Effectiveness and Health Policy (IECS-CONICET), Dr Emilio Ravignani 2024 (C1014CPV), Buenos Aires, Argentina.

Agustín Ciapponi (A)

Centre for Research in Epidemiology and Public Health, Institute for Clinical Effectiveness and Health Policy (IECS-CONICET), Dr Emilio Ravignani 2024 (C1014CPV), Buenos Aires, Argentina.

Osvaldo Ulises Garay (OU)

Institute for Clinical Effectiveness and Health Policy (IECS-CONICET), Dr Emilio Ravignani 2024 (C1014CPV), Buenos Aires, Argentina.

Andrés Pichón Riviere (AP)

Centre for Research in Epidemiology and Public Health, Institute for Clinical Effectiveness and Health Policy (IECS-CONICET), Dr Emilio Ravignani 2024 (C1014CPV), Buenos Aires, Argentina.

Alfredo Palacios (A)

Center for Study of State and Society (CEDES), Sánchez de Bustamante 27 (C1173AAA) CABA, Buenos Aires, Argentina.

Mariana Cremonte (M)

Group of Psychoactive Substances and injuries due to external cause, Institute of Basic, Applied Psychology and Technology (IPSIBAT) CONICET National University of Mar del Plata, Dean Funes 3250, B7602AYJ, Mar del Plata, Buenos Aires, Argentina.

Federico Augustovski (F)

Centre for Research in Epidemiology and Public Health, Institute for Clinical Effectiveness and Health Policy (IECS-CONICET), Dr Emilio Ravignani 2024 (C1014CPV), Buenos Aires, Argentina.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH